1. Home
  2. STVN vs UMBF Comparison

STVN vs UMBF Comparison

Compare STVN & UMBF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • UMBF
  • Stock Information
  • Founded
  • STVN 1949
  • UMBF 1913
  • Country
  • STVN Italy
  • UMBF United States
  • Employees
  • STVN N/A
  • UMBF N/A
  • Industry
  • STVN Containers/Packaging
  • UMBF Major Banks
  • Sector
  • STVN Consumer Discretionary
  • UMBF Finance
  • Exchange
  • STVN Nasdaq
  • UMBF Nasdaq
  • Market Cap
  • STVN 6.2B
  • UMBF 5.2B
  • IPO Year
  • STVN 2021
  • UMBF N/A
  • Fundamental
  • Price
  • STVN $19.02
  • UMBF $121.49
  • Analyst Decision
  • STVN Buy
  • UMBF Buy
  • Analyst Count
  • STVN 3
  • UMBF 6
  • Target Price
  • STVN $29.33
  • UMBF $115.00
  • AVG Volume (30 Days)
  • STVN 633.0K
  • UMBF 477.5K
  • Earning Date
  • STVN 11-05-2024
  • UMBF 10-29-2024
  • Dividend Yield
  • STVN 0.31%
  • UMBF 1.32%
  • EPS Growth
  • STVN N/A
  • UMBF 2.85
  • EPS
  • STVN 0.48
  • UMBF 8.01
  • Revenue
  • STVN $1,220,254,294.00
  • UMBF $1,523,550,000.00
  • Revenue This Year
  • STVN $3.01
  • UMBF N/A
  • Revenue Next Year
  • STVN $7.78
  • UMBF $46.23
  • P/E Ratio
  • STVN $39.99
  • UMBF $15.16
  • Revenue Growth
  • STVN 3.53
  • UMBF 7.93
  • 52 Week Low
  • STVN $16.56
  • UMBF $69.96
  • 52 Week High
  • STVN $34.73
  • UMBF $128.73
  • Technical
  • Relative Strength Index (RSI)
  • STVN 43.43
  • UMBF 62.16
  • Support Level
  • STVN $17.12
  • UMBF $121.03
  • Resistance Level
  • STVN $22.07
  • UMBF $128.35
  • Average True Range (ATR)
  • STVN 1.37
  • UMBF 3.74
  • MACD
  • STVN -0.05
  • UMBF 0.83
  • Stochastic Oscillator
  • STVN 21.48
  • UMBF 68.74

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About UMBF UMB Financial Corporation

UMB Financial Corp, or UMBF, is a financial services holding company offering a suite of banking, asset management, and health spending solutions. Its customer base includes commercial, institutional, and personal customers across the United States. The company's banking subsidiaries own and operate banking and wealth-management centers mostly throughout the Midwest and Southwest regions of the U.S. Subsidiaries of the holding company and its lead bank, UMB Bank, include mutual fund and alternative investment services groups, single-purpose companies that deal with brokerage services and insurance, and a registered investment advisory. The bank's revenue is split nearly evenly between interest income and noninterest income.

Share on Social Networks: